![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: RPS6KB1 |
Gene summary for RPS6KB1 |
![]() |
Gene information | Species | Human | Gene symbol | RPS6KB1 | Gene ID | 6198 |
Gene name | ribosomal protein S6 kinase B1 | |
Gene Alias | PS6K | |
Cytomap | 17q23.1 | |
Gene Type | protein-coding | GO ID | GO:0000082 | UniProtAcc | P23443 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
6198 | RPS6KB1 | P83T-E | Human | Esophagus | ESCC | 2.39e-15 | 5.29e-01 | 0.1738 |
6198 | RPS6KB1 | P84T-E | Human | Esophagus | ESCC | 1.49e-02 | 2.44e-01 | 0.0933 |
6198 | RPS6KB1 | P91T-E | Human | Esophagus | ESCC | 3.38e-07 | 7.55e-01 | 0.1828 |
6198 | RPS6KB1 | P107T-E | Human | Esophagus | ESCC | 3.60e-20 | 3.93e-01 | 0.171 |
6198 | RPS6KB1 | P126T-E | Human | Esophagus | ESCC | 1.92e-05 | 6.87e-01 | 0.1125 |
6198 | RPS6KB1 | P127T-E | Human | Esophagus | ESCC | 5.03e-20 | 1.67e-01 | 0.0826 |
6198 | RPS6KB1 | P128T-E | Human | Esophagus | ESCC | 1.39e-35 | 9.96e-01 | 0.1241 |
6198 | RPS6KB1 | P130T-E | Human | Esophagus | ESCC | 1.04e-40 | 7.08e-01 | 0.1676 |
6198 | RPS6KB1 | HCC1_Meng | Human | Liver | HCC | 8.90e-78 | 2.41e-01 | 0.0246 |
6198 | RPS6KB1 | HCC2_Meng | Human | Liver | HCC | 9.80e-15 | 5.43e-02 | 0.0107 |
6198 | RPS6KB1 | HCC1 | Human | Liver | HCC | 5.46e-04 | 2.42e+00 | 0.5336 |
6198 | RPS6KB1 | HCC2 | Human | Liver | HCC | 2.81e-10 | 2.89e+00 | 0.5341 |
6198 | RPS6KB1 | Pt13.b | Human | Liver | HCC | 3.31e-06 | 1.05e-01 | 0.0251 |
6198 | RPS6KB1 | S014 | Human | Liver | HCC | 3.21e-06 | 2.41e-01 | 0.2254 |
6198 | RPS6KB1 | S015 | Human | Liver | HCC | 3.06e-07 | 3.67e-01 | 0.2375 |
6198 | RPS6KB1 | S016 | Human | Liver | HCC | 2.61e-06 | 2.13e-01 | 0.2243 |
6198 | RPS6KB1 | S028 | Human | Liver | HCC | 2.70e-13 | 5.35e-01 | 0.2503 |
6198 | RPS6KB1 | S029 | Human | Liver | HCC | 1.55e-11 | 5.50e-01 | 0.2581 |
6198 | RPS6KB1 | C04 | Human | Oral cavity | OSCC | 1.17e-04 | 3.84e-01 | 0.2633 |
6198 | RPS6KB1 | C21 | Human | Oral cavity | OSCC | 7.73e-09 | 5.03e-01 | 0.2678 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000641310 | Endometrium | AEH | translational initiation | 42/2100 | 118/18723 | 2.68e-12 | 4.67e-10 | 42 |
GO:000641716 | Endometrium | AEH | regulation of translation | 94/2100 | 468/18723 | 1.14e-08 | 7.62e-07 | 94 |
GO:004572715 | Endometrium | AEH | positive regulation of translation | 38/2100 | 136/18723 | 6.37e-08 | 3.38e-06 | 38 |
GO:003425015 | Endometrium | AEH | positive regulation of cellular amide metabolic process | 42/2100 | 162/18723 | 1.35e-07 | 6.12e-06 | 42 |
GO:00064467 | Endometrium | AEH | regulation of translational initiation | 25/2100 | 79/18723 | 8.99e-07 | 3.19e-05 | 25 |
GO:19016539 | Endometrium | AEH | cellular response to peptide | 64/2100 | 359/18723 | 1.16e-04 | 1.63e-03 | 64 |
GO:00457877 | Endometrium | AEH | positive regulation of cell cycle | 56/2100 | 313/18723 | 2.73e-04 | 3.14e-03 | 56 |
GO:004343410 | Endometrium | AEH | response to peptide hormone | 70/2100 | 414/18723 | 2.93e-04 | 3.35e-03 | 70 |
GO:003166716 | Endometrium | AEH | response to nutrient levels | 78/2100 | 474/18723 | 3.26e-04 | 3.64e-03 | 78 |
GO:00328699 | Endometrium | AEH | cellular response to insulin stimulus | 37/2100 | 203/18723 | 1.97e-03 | 1.54e-02 | 37 |
GO:00713758 | Endometrium | AEH | cellular response to peptide hormone stimulus | 49/2100 | 290/18723 | 2.24e-03 | 1.72e-02 | 49 |
GO:00447726 | Endometrium | AEH | mitotic cell cycle phase transition | 67/2100 | 424/18723 | 2.37e-03 | 1.78e-02 | 67 |
GO:00082866 | Endometrium | AEH | insulin receptor signaling pathway | 23/2100 | 116/18723 | 4.58e-03 | 2.95e-02 | 23 |
GO:00328689 | Endometrium | AEH | response to insulin | 44/2100 | 264/18723 | 4.70e-03 | 3.00e-02 | 44 |
GO:00181058 | Endometrium | AEH | peptidyl-serine phosphorylation | 50/2100 | 315/18723 | 7.20e-03 | 4.13e-02 | 50 |
GO:00459317 | Endometrium | AEH | positive regulation of mitotic cell cycle | 23/2100 | 121/18723 | 7.76e-03 | 4.33e-02 | 23 |
GO:000641315 | Endometrium | EEC | translational initiation | 42/2168 | 118/18723 | 7.65e-12 | 1.24e-09 | 42 |
GO:000641717 | Endometrium | EEC | regulation of translation | 94/2168 | 468/18723 | 5.37e-08 | 2.88e-06 | 94 |
GO:004572716 | Endometrium | EEC | positive regulation of translation | 38/2168 | 136/18723 | 1.47e-07 | 6.89e-06 | 38 |
GO:003425016 | Endometrium | EEC | positive regulation of cellular amide metabolic process | 42/2168 | 162/18723 | 3.24e-07 | 1.32e-05 | 42 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0471427 | Endometrium | EEC | Thermogenesis | 85/1237 | 232/8465 | 2.79e-17 | 7.05e-16 | 5.26e-16 | 85 |
hsa0466621 | Endometrium | EEC | Fc gamma R-mediated phagocytosis | 27/1237 | 97/8465 | 5.15e-04 | 3.83e-03 | 2.85e-03 | 27 |
hsa0406624 | Endometrium | EEC | HIF-1 signaling pathway | 29/1237 | 109/8465 | 7.33e-04 | 5.13e-03 | 3.82e-03 | 29 |
hsa043502 | Endometrium | EEC | TGF-beta signaling pathway | 26/1237 | 108/8465 | 5.95e-03 | 3.12e-02 | 2.33e-02 | 26 |
hsa0471436 | Endometrium | EEC | Thermogenesis | 85/1237 | 232/8465 | 2.79e-17 | 7.05e-16 | 5.26e-16 | 85 |
hsa0466631 | Endometrium | EEC | Fc gamma R-mediated phagocytosis | 27/1237 | 97/8465 | 5.15e-04 | 3.83e-03 | 2.85e-03 | 27 |
hsa0406634 | Endometrium | EEC | HIF-1 signaling pathway | 29/1237 | 109/8465 | 7.33e-04 | 5.13e-03 | 3.82e-03 | 29 |
hsa043503 | Endometrium | EEC | TGF-beta signaling pathway | 26/1237 | 108/8465 | 5.95e-03 | 3.12e-02 | 2.33e-02 | 26 |
hsa05131211 | Esophagus | ESCC | Shigellosis | 176/4205 | 247/8465 | 2.27e-12 | 4.01e-11 | 2.05e-11 | 176 |
hsa04714211 | Esophagus | ESCC | Thermogenesis | 163/4205 | 232/8465 | 9.22e-11 | 1.14e-09 | 5.86e-10 | 163 |
hsa05170210 | Esophagus | ESCC | Human immunodeficiency virus 1 infection | 147/4205 | 212/8465 | 3.37e-09 | 3.53e-08 | 1.81e-08 | 147 |
hsa0521020 | Esophagus | ESCC | Colorectal cancer | 69/4205 | 86/8465 | 4.06e-09 | 4.13e-08 | 2.11e-08 | 69 |
hsa0521216 | Esophagus | ESCC | Pancreatic cancer | 62/4205 | 76/8465 | 7.37e-09 | 6.85e-08 | 3.51e-08 | 62 |
hsa0516510 | Esophagus | ESCC | Human papillomavirus infection | 215/4205 | 331/8465 | 7.86e-09 | 7.12e-08 | 3.65e-08 | 215 |
hsa0414010 | Esophagus | ESCC | Autophagy - animal | 101/4205 | 141/8465 | 7.60e-08 | 6.21e-07 | 3.18e-07 | 101 |
hsa0520529 | Esophagus | ESCC | Proteoglycans in cancer | 138/4205 | 205/8465 | 1.79e-07 | 1.40e-06 | 7.15e-07 | 138 |
hsa05163210 | Esophagus | ESCC | Human cytomegalovirus infection | 148/4205 | 225/8465 | 5.73e-07 | 4.00e-06 | 2.05e-06 | 148 |
hsa0406629 | Esophagus | ESCC | HIF-1 signaling pathway | 75/4205 | 109/8465 | 3.66e-05 | 1.68e-04 | 8.60e-05 | 75 |
hsa0522518 | Esophagus | ESCC | Hepatocellular carcinoma | 109/4205 | 168/8465 | 4.27e-05 | 1.88e-04 | 9.64e-05 | 109 |
hsa052215 | Esophagus | ESCC | Acute myeloid leukemia | 49/4205 | 67/8465 | 7.43e-05 | 3.07e-04 | 1.57e-04 | 49 |
Page: 1 2 3 4 5 6 7 8 9 10 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
RPS6KB1 | SNV | Missense_Mutation | novel | c.283N>T | p.Arg95Trp | p.R95W | P23443 | protein_coding | deleterious(0) | probably_damaging(0.968) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
RPS6KB1 | SNV | Missense_Mutation | c.655C>G | p.Leu219Val | p.L219V | P23443 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-BH-A0B4-01 | Breast | breast invasive carcinoma | Male | >=65 | III/IV | Hormone Therapy | tamoxiphen | SD | |
RPS6KB1 | SNV | Missense_Mutation | c.1114N>A | p.Leu372Met | p.L372M | P23443 | protein_coding | tolerated(0.1) | benign(0.243) | TCGA-D8-A1JJ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicine | SD | |
RPS6KB1 | SNV | Missense_Mutation | c.142N>A | p.Gly48Ser | p.G48S | P23443 | protein_coding | tolerated(0.75) | benign(0.007) | TCGA-E2-A1LK-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD | |
RPS6KB1 | SNV | Missense_Mutation | c.866G>A | p.Gly289Glu | p.G289E | P23443 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-JW-A5VL-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
RPS6KB1 | SNV | Missense_Mutation | novel | c.1480G>A | p.Ala494Thr | p.A494T | P23443 | protein_coding | deleterious_low_confidence(0.01) | benign(0.388) | TCGA-AA-3949-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
RPS6KB1 | SNV | Missense_Mutation | c.1402N>A | p.Pro468Thr | p.P468T | P23443 | protein_coding | tolerated_low_confidence(0.38) | benign(0) | TCGA-AA-3977-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
RPS6KB1 | SNV | Missense_Mutation | novel | c.283N>T | p.Arg95Trp | p.R95W | P23443 | protein_coding | deleterious(0) | probably_damaging(0.968) | TCGA-AZ-4315-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
RPS6KB1 | SNV | Missense_Mutation | novel | c.1053N>A | p.Phe351Leu | p.F351L | P23443 | protein_coding | deleterious(0) | probably_damaging(0.984) | TCGA-AZ-4315-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
RPS6KB1 | insertion | Frame_Shift_Ins | novel | c.1524dupA | p.Gln509ThrfsTer24 | p.Q509Tfs*24 | P23443 | protein_coding | TCGA-AA-3877-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
6198 | RPS6KB1 | CELL SURFACE, SERINE THREONINE KINASE, DRUGGABLE GENOME, KINASE, ENZYME, CLINICALLY ACTIONABLE | inhibitor | CHEMBL3545134 | LY-2780301 | |
6198 | RPS6KB1 | CELL SURFACE, SERINE THREONINE KINASE, DRUGGABLE GENOME, KINASE, ENZYME, CLINICALLY ACTIONABLE | AR-A014418 | CHEMBL259850 | ||
6198 | RPS6KB1 | CELL SURFACE, SERINE THREONINE KINASE, DRUGGABLE GENOME, KINASE, ENZYME, CLINICALLY ACTIONABLE | LY-2584702 | LY-2584702 | ||
6198 | RPS6KB1 | CELL SURFACE, SERINE THREONINE KINASE, DRUGGABLE GENOME, KINASE, ENZYME, CLINICALLY ACTIONABLE | JNK INHIBITOR VIII | CHEMBL210618 | ||
6198 | RPS6KB1 | CELL SURFACE, SERINE THREONINE KINASE, DRUGGABLE GENOME, KINASE, ENZYME, CLINICALLY ACTIONABLE | SP-600125 | SP-600125 | ||
6198 | RPS6KB1 | CELL SURFACE, SERINE THREONINE KINASE, DRUGGABLE GENOME, KINASE, ENZYME, CLINICALLY ACTIONABLE | inhibitor | 249565928 | LY-2584702 | |
6198 | RPS6KB1 | CELL SURFACE, SERINE THREONINE KINASE, DRUGGABLE GENOME, KINASE, ENZYME, CLINICALLY ACTIONABLE | DOVITINIB | DOVITINIB | ||
6198 | RPS6KB1 | CELL SURFACE, SERINE THREONINE KINASE, DRUGGABLE GENOME, KINASE, ENZYME, CLINICALLY ACTIONABLE | SOTRASTAURIN | SOTRASTAURIN | ||
6198 | RPS6KB1 | CELL SURFACE, SERINE THREONINE KINASE, DRUGGABLE GENOME, KINASE, ENZYME, CLINICALLY ACTIONABLE | inhibitor | 249565861 | ||
6198 | RPS6KB1 | CELL SURFACE, SERINE THREONINE KINASE, DRUGGABLE GENOME, KINASE, ENZYME, CLINICALLY ACTIONABLE | GNF-PF-2301 | CHEMBL578061 |
Page: 1 2 3 4 5 |